1/4
Wells Fargo ($WFC) is now live on Injective, giving traders one of the few onchain venues to access the market 24/7 with leverage. A familiar name from traditional finance is entering crypto native markets. Worth watching
1/4
The biggest shift in finance may not be the asset being traded. It may be the infrastructure behind the trade. The CFTC has now approved a US derivatives exchange and clearinghouse using blockchain for execution and settlement.
4/4
Injective has been building in that direction for years. Its onchain derivatives markets have processed over $85B, while the Canary Staked INJ ETF (INJC) gives investors Nasdaq listed exposure to INJ and staking rewards.
1/4
The biggest shift in finance may not be the asset being traded. It may be the infrastructure behind the trade. The CFTC has now approved a US derivatives exchange and clearinghouse using blockchain for execution and settlement.
3/4
That moves the conversation beyond whether onchain markets belong in finance. The question is whether they can meet the rules. The CFTC's message: innovation can happen on new rails, with real safeguards.
1/4
Tokenization needs more than putting assets on a blockchain.
It needs infrastructure to issue them, track ownership, manage transfers and settle transactions.
Injective just made a major move on that front.
1/4
The CFTC’s move matters beyond one exchange. It shows blockchain based derivatives can fit inside the US regulatory framework. The bigger shift: the law sets standards for markets, not the technology running underneath them.
1/4
Injective’s Veyra upgrade is gaining serious momentum.
The community is sending a strong signal in favour of what could become another major step forward for the network.
But this is bigger than just another upgrade. It's about what Injective is preparing to build. 🧵
1/1
$INJ is opening two major doors at once.
In the US, Canary’s staked INJ ETF is now trading on Nasdaq as $INJC.
In Europe, INJ’s MiCA whitepaper is in ESMA’s register.
Different routes, same direction broader market access today.
1/4
Injective USDC is moving beyond a single chain story. Cosmos Hub has moved its treasury, and dYdX is now considering the same shift for the USDC backing its markets. That’s a meaningful step toward one shared standard.
1/4
Twelve months can change a lot.
Injective’s latest timeline shows a year of building across the chain, markets, real world assets, access, AI and regulated finance.
And this is only a glimpse of what happened.
1/4
Most people only get to follow a company like Anthropic once it’s already public.
Injective is opening a different window: its $ANT pre IPO market is live ahead of the company’s anticipated Nasdaq debut.